Company profile: Kernel
1.1 - Company Overview
Company description
- Provider of non-invasive brain-recording technologies, including Kernel Flow2, a time-domain fNIRS and EEG neuro measurement platform, and Kernel Flow, a multimodal headset combining hemodynamic and EEG data. Services include study design consulting, data management software, custom fNIRS/TD-fNIRS analysis development, and automated quality control metrics.
Products and services
- Data Management Software: Operator-guided platform that organizes study visit data, minimizes entry errors, and standardizes procedures by guiding operators through each step and ensuring consistent data handling
- Kernel Flow: Multimodal headset that combines hemodynamic and EEG data to deliver a comprehensive view of cortical brain activity for functional measurement across the cortex
- Kernel Flow2: Non-invasive neuro measurement platform using time-domain functional near-infrared spectroscopy and EEG to translate neuroimaging research findings into clinical use for brain-recording applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Kernel
AlgoTx
HQ: France
Website
- Description: Provider of topical hydrogel therapies for complex pain, developing ATX01 to inhibit nociceptive sodium channels for targeted relief in chemotherapy-induced peripheral neuropathy and erythromelalgia, with plans to address additional peripheral neuropathic pain conditions such as painful diabetic peripheral neuropathy and phantom limb pain.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AlgoTx company profile →
Jupiter Neurosciences
HQ: United States
Website
- Description: Provider of biotechnology therapies targeting Alzheimer's and rare neurological disorders, including JOTROL, an oral micellar resveratrol formulation designed to deliver therapeutic doses without side effects. The company pursues a pipeline strategy using a Phase I study to enable trials for three rare diseases and mild cognitive impairment to proceed directly to Phase II.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jupiter Neurosciences company profile →
Neuronetics
HQ: United States
Website
- Description: Provider of non-drug, non-invasive TMS therapies for mental health, including NeuroStar Advanced Therapy for major depressive disorder using precise magnetic stimulation, supported by the TrakStar HIPAA-compliant practice management system and features like MT Assist and Contact Sensing for accurate dosing and real-time treatment feedback.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neuronetics company profile →
Adapt Pharma
HQ: United States
Website
- Description: Provider of therapeutic treatments for patients with special medical conditions, including NARCAN (naloxone hydrochloride) Nasal Spray, an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adapt Pharma company profile →
Phagenesis
HQ: United Kingdom
Website
- Description: Provider of neurostimulation solutions for dysphagia treatment, developing the Phagenyx System, which delivers Pharyngeal Electrical Stimulation to restore neurological control of swallowing. The system tailors stimulation to patient sensory capacity and uses a dual-function catheter for feeding and electrical therapy, harnessing neuroplasticity to improve safe swallowing in patients, including those post-stroke or with neuro-deficit diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phagenesis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Kernel
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Kernel
2.2 - Growth funds investing in similar companies to Kernel
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Kernel
4.2 - Public trading comparable groups for Kernel
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →